Abbvie Inc
NYSE:ABBV
Abbvie Inc
Retained Earnings
Abbvie Inc
Retained Earnings Peer Comparison
Competitive Retained Earnings Analysis
Latest Figures & CAGR of Competitors
Company | Retained Earnings | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Abbvie Inc
NYSE:ABBV
|
Retained Earnings
-$1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Retained Earnings
$16.3B
|
CAGR 3-Years
4%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
10%
|
|
Amgen Inc
NASDAQ:AMGN
|
Retained Earnings
-$26.5B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-13%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Retained Earnings
$10.1B
|
CAGR 3-Years
128%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Retained Earnings
$27.3B
|
CAGR 3-Years
36%
|
CAGR 5-Years
39%
|
CAGR 10-Years
N/A
|
|
Seagen Inc
NASDAQ:SGEN
|
Retained Earnings
-$2.8B
|
CAGR 3-Years
-39%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
-14%
|
See Also
What is Abbvie Inc's Retained Earnings?
Retained Earnings
-1B
USD
Based on the financial report for Dec 31, 2023, Abbvie Inc's Retained Earnings amounts to -1B USD.